Verified peer comparison
CytoMed Therapeutics vs BeLive Holdings Financial Comparison
Direct answer
CytoMed Therapeutics and BeLive Holdings are compared on the same basis.
The comparison uses 2025 results reported in SGD.
Common metrics include Revenue, Operating income, Net income, Operating cash flow.
Alpha Vantage
Get free CytoMed Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- CytoMed Therapeutics Revenue
- 319,201 SGD
- BeLive Holdings Revenue
- 757,159 SGD
- CytoMed Therapeutics Operating income
- -4,519,770 SGD
- BeLive Holdings Operating income
- -6,706,466 SGD